Iodoacetamide → HCID 10281490, compound

HRID 1072376Notes

Reaction equation

HRID 1072376 reaction equation
[OH:1][C@@H:2]([C@H:4]1[C:46](=[O:47])[N:6]2[C:7]([C:33]([O:35]CC3C=CC([N+]([O-])=O)=CC=3)=[O:34])=[C:8]([C:11]3[S:15][C:14]4=[C:16]([C:19]([C:21]5[CH:22]=[N:23][CH:24]=[C:25]([C:27]6[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=6)[CH:26]=5)=[O:20])[N:17]=[CH:18][N:13]4[CH:12]=3)[C@H:9]([CH3:10])[C@H:5]12)[CH3:3].I[CH2:49][C:50]([NH2:52])=[O:51]>>[C:50]([CH2:49][N+:23]1[CH:24]=[C:25]([C:27]2[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=2)[CH:26]=[C:21]([C:19]([C:16]2[N:17]=[CH:18][N:13]3[CH:12]=[C:11]([C:8]4[C@H:9]([CH3:10])[C@@H:5]5[C@@H:4]([C@H:2]([OH:1])[CH3:3])[C:46](=[O:47])[N:6]5[C:7]=4[C:33]([O-:35])=[O:34])[S:15][C:14]=23)=[O:20])[CH:22]=1)(=[O:51])[NH2:52]

Participants

3

Procedure

An N-quaternarized compound (91 mg) was prepared in substantially the same manner as in Example 24, except that 97 mg of 4-nitrobenzyl (1S,5R,6S)-6-((1R)-1-hydroxyethyl)-1-methyl-2-[7-(5-phenylpyridin-3-yl)carbonylimidazo[5,1-b]thiazol-2-yl]-1-carbapen-2-em-3-carboxylate and 185 mg of 2-iodoacetamide were used as the starting compounds. The title compound (16.7 mg) was prepared in substantially the same manner as in step c) of Example 1, except that this compound was used as the starting compound.

Sources & evidence

ORD record
ord-6d6b88d61fbf454da547f73e31df2f59
Source dataset
uspto-grants-2005_06
Patent number
US06908913B2

Reaction notes

Loading…